The aim of this study was to assess the correlation between the estimated adherence of HIV-1 infected patients with antiretroviral (ARV) therapy failure and drug-resistant mutations. We studied 40 patients with virological and immunological ARV-therapy failure. In order to assess the adherence of patients we used the SERAD questionnaire. Genomic sequencing of the HIV-1 pol gene was performed. 100% adherence was reported by 27 patients (67.5%) (adherent patients). Multivariate analysis showed that only baseline and nadir CD4+ counts maintained a significant correlation with the adherence. For PR and NNRTI mutations, we did not find any difference between the two groups of patients. Baseline NRTI mutations were higher in adherent patients tha...
Objective: This study aims to investigate the prevalence and types of drug resistance mutations amon...
Antiretroviral therapy (ARV) exert a selective pressure on HIV-1 and may select viral drug resistant...
In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA ...
The aim of this study was to assess the correlation between the estimated adherence of HIV-1 infecte...
The aim of this study was to assess the correlation between the estimated adherence of HIV-1 infecte...
Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive patients. Vi...
BACKGROUND:Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive p...
We analyzed the first 96 patients tested for HIV resistance to antiretroviral therapy in three Brazi...
We explored the relationship between HIV-1 drug resistance in treatment-experienced patients and dis...
Adherence to antiretroviral therapy affects the pharmacokinetics of antiviral drugs and activates a ...
Adherence to antiretroviral therapy affects the pharmacokinetics of antiviral drugs and activates a ...
As the human immunodeficiency virus (HIV-1) epidemic enters its fourth decade, we continue to advanc...
Thirty-five HIV-1 infected patients showing clinical and/or immunological failure to first line anti...
Little is known about factors involved in virological response to treatment changes guided by genoty...
Resistance-mutation patterns in the reverse transcriptase (RT) and protease genes of HIV-1 were anal...
Objective: This study aims to investigate the prevalence and types of drug resistance mutations amon...
Antiretroviral therapy (ARV) exert a selective pressure on HIV-1 and may select viral drug resistant...
In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA ...
The aim of this study was to assess the correlation between the estimated adherence of HIV-1 infecte...
The aim of this study was to assess the correlation between the estimated adherence of HIV-1 infecte...
Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive patients. Vi...
BACKGROUND:Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive p...
We analyzed the first 96 patients tested for HIV resistance to antiretroviral therapy in three Brazi...
We explored the relationship between HIV-1 drug resistance in treatment-experienced patients and dis...
Adherence to antiretroviral therapy affects the pharmacokinetics of antiviral drugs and activates a ...
Adherence to antiretroviral therapy affects the pharmacokinetics of antiviral drugs and activates a ...
As the human immunodeficiency virus (HIV-1) epidemic enters its fourth decade, we continue to advanc...
Thirty-five HIV-1 infected patients showing clinical and/or immunological failure to first line anti...
Little is known about factors involved in virological response to treatment changes guided by genoty...
Resistance-mutation patterns in the reverse transcriptase (RT) and protease genes of HIV-1 were anal...
Objective: This study aims to investigate the prevalence and types of drug resistance mutations amon...
Antiretroviral therapy (ARV) exert a selective pressure on HIV-1 and may select viral drug resistant...
In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA ...